Multi-target treatment of bone cancer pain using synergistic combinations of pharmacological compounds in experimental animals

Multi-target treatment of bone cancer pain using synergistic combinations of pharmacological... In this issue of the Scandinavian Journal of Pain, González- Rodríguez and coworkers report about treatment of bone cancer pain using synergistic combinations of a dual enkephalinase inhibitor with various other drugs in experimental animals [1]. In the clinic, cancer, particularly that originating in the lung, breast and prostate, frequently metastasizes to bone, where it may cause pain, although not in all subjects or at all metastasized sites [2]. Bone cancer-induced pain may progress quickly from intermittent to continuous and further to breakthrough pain with episodes of extreme pain that occur spontaneously or that are induced e.g. by weight-bearing on the tumour-affected bones [3]. Additionally, bone cancer pain can be accompanied by mechanical hypersensitivity, due to which even gentle movements or touching the skin close to the tumour may induce strong pain [4,5]. These bone cancer-induced symptoms can severely reduce quality of life.1Experimental animal models in the study of mechanisms of bone cancer painDevelopment of experimental animal models for the study of bone cancer pain has significantly advanced our understanding of underlying mechanisms. Behaviorally, animal models of bone cancer pain induce in the affected limb guarding and mechanical hypersensitivity mirroring continuous pain and tactile allodynia in the clinic [4]. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Scandinavian Journal of Pain de Gruyter

Multi-target treatment of bone cancer pain using synergistic combinations of pharmacological compounds in experimental animals

Loading next page...
 
/lp/degruyter/multi-target-treatment-of-bone-cancer-pain-using-synergistic-rMLdYtRxjk
Publisher
de Gruyter
Copyright
© 2016 Scandinavian Association for the Study of Pain
ISSN
1877-8860
eISSN
1877-8879
D.O.I.
10.1016/j.sjpain.2016.11.001
Publisher site
See Article on Publisher Site

Abstract

In this issue of the Scandinavian Journal of Pain, González- Rodríguez and coworkers report about treatment of bone cancer pain using synergistic combinations of a dual enkephalinase inhibitor with various other drugs in experimental animals [1]. In the clinic, cancer, particularly that originating in the lung, breast and prostate, frequently metastasizes to bone, where it may cause pain, although not in all subjects or at all metastasized sites [2]. Bone cancer-induced pain may progress quickly from intermittent to continuous and further to breakthrough pain with episodes of extreme pain that occur spontaneously or that are induced e.g. by weight-bearing on the tumour-affected bones [3]. Additionally, bone cancer pain can be accompanied by mechanical hypersensitivity, due to which even gentle movements or touching the skin close to the tumour may induce strong pain [4,5]. These bone cancer-induced symptoms can severely reduce quality of life.1Experimental animal models in the study of mechanisms of bone cancer painDevelopment of experimental animal models for the study of bone cancer pain has significantly advanced our understanding of underlying mechanisms. Behaviorally, animal models of bone cancer pain induce in the affected limb guarding and mechanical hypersensitivity mirroring continuous pain and tactile allodynia in the clinic [4].

Journal

Scandinavian Journal of Painde Gruyter

Published: Jan 1, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off